Nemaura Medical Inc. NMRD · Stock Open Nemaura Medical Inc. in new tab
Nemaura Medical Inc. Analysis (NMRD)
Is Nemaura Medical Inc. a good investment? Nemaura Medical Inc. (NMRD) is currently trading at 0.000100 USD.
Earnings Schedule: Nemaura Medical Inc. is expected to release its next earnings report on Nov. 17, 2026. The market consensus estimate for Forward EPS is -0.44.
Investor FAQ
Does Nemaura Medical Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Nemaura Medical Inc.?
Nemaura Medical Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 17, 2026. The company currently has a trailing EPS of -0.39.
Company Profile
Nemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York.
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 5, 2019 | 1:10 |
Community Discussion